Neumora Therapeutics, Inc. (NMRA)
(Real Time Quote from BATS)
$11.70 USD
-0.09 (-0.76%)
Updated Aug 8, 2024 12:06 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.39 |
EPS Last Quarter | -0.37 |
Last EPS Surprise | 0.00% |
ABR | 1.25 |
Earnings ESP
|
2.56% |
---|---|
Current Year | -1.48 |
Next Year | -1.56 |
EPS (TTM) | -2.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.39 | -0.40 | -1.48 | -1.56 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.37 | -0.37 | -1.43 | -1.57 |
High Estimate | -0.35 | -0.35 | -1.37 | -1.42 |
Low Estimate | -0.44 | -0.45 | -1.64 | -1.75 |
Year ago EPS | -1.14 | -0.71 | -3.63 | -1.48 |
Year over Year Growth Est. | 65.79% | 43.66% | 59.23% | -5.57% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.39 | -0.40 | -1.48 | -1.56 |
7 Days Ago | -0.39 | -0.39 | -1.46 | -1.54 |
30 Days Ago | -0.39 | -0.39 | -1.46 | -1.54 |
60 Days Ago | -0.39 | -0.39 | -1.46 | -1.54 |
90 Days Ago | -0.39 | -0.39 | -1.47 | -1.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.39 | -1.48 | -1.64 |
Zacks Consensus Estimate | -0.39 | -0.40 | -1.48 | -1.56 |
Earnings ESP | 2.56% | 1.68% | -0.34% | -5.30% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.37 | -0.34 | -0.71 | -1.14 | NA |
Estimate | -0.37 | -0.35 | -0.65 | -0.48 | NA |
Difference | 0.00 | 0.01 | -0.06 | -0.66 | -0.18 |
Surprise | 0.00% | 2.86% | -9.23% | -137.50% | -35.97% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more